Skip to main content

Advertisement

Log in

Frequency of depression among oncology outpatients and association with other symptoms

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Depression occurs among an estimated 15% of cancer patients (range, 1–77.5%). Our main objective was to identify the frequency of reported depression by using the Brief Edinburgh Depression Scale (BEDS) among cancer outpatients. Our secondary objective was to identify associated symptoms of cancer using the Edmonton Symptom Assessment System (ESAS) and to evaluate the screening performance of depression between ESAS and BEDS.

Methods

In this multicenter prospective study conducted, we used the ESAS to collect information on nine symptoms: pain, fatigue, nausea, depression, anxiety, drowsiness, shortness of breath, lack of appetite, and feeling of well-being (each rated from 0 to 10). The BEDS was used to assess for “probable depression” (score >6). Data were analyzed using a parametric and nonparametric test.

Results

A total of 146 patients completed the study. The prevalence of probable depression was 43/146 (29%). Probable depression was associated with increased fatigue (p = 0.008), depression (p < 0.0001), anxiety (p < 0.0001), shortness of breath (p = 0.01), and decreased feeling of well-being (p < 0.001). Among patients with probable depression, 42 (98%) patients were not using antidepressants. Regarding the sensitivity and the specificity, we determined that the optimal cutoff for using the ESAS as a depression screening tool was ≥2.

Conclusion

We found significant associations between probable depression as determined with the BEDS and five symptoms as detected with the ESAS. The vast majority of patients with probable depression were not receiving pharmacological treatment. Depression should be suspected in patients with higher symptom distress as for any one of these 5 ESAS items.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Trask PC (2004) Assessment of depression in cancer patients. J Natl Cancer Inst Monogr 32:80–92

    Google Scholar 

  2. Hotopf M, Chidgey J, Addington-Hall J, Ly KL (2002) Depression in advanced disease: a systematic review. Part 1. Prevalence and case finding. Palliat Med 16:81–97

    Article  PubMed  CAS  Google Scholar 

  3. Meyer HA, Sinnott C, Seed PT (2003) Depressive symptoms in advanced cancer. Part 1. Assessing depression: the mood evaluation questionnaire. Palliat Med 17:596–603

    Article  PubMed  Google Scholar 

  4. Reeve JL, Lloyd-Williams M, Dowrick C (2008) Revisiting depression in palliative care settings: the need to focus on clinical utility over validity. Palliat Med 22:383–391

    Article  PubMed  CAS  Google Scholar 

  5. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12:160–174

    Article  PubMed  Google Scholar 

  6. Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald DE, Edgerton S (1998) Oncologists' recognition of depression in their patients with cancer. J Clin Oncol 16:1594–1600

    PubMed  CAS  Google Scholar 

  7. Fallowfield L, Ratcliffe D, Jenkins V, Saul J (2001) Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 84:1011–1015

    Article  PubMed  CAS  Google Scholar 

  8. Lawrie I, Lloyd-Williams M, Taylor F (2004) How do palliative medicine physicians assess and manage depression. Palliat Med 18:234–238

    Article  PubMed  Google Scholar 

  9. Breitbart W (1995) Identifying patients at risk for, and treatment of major psychiatric complications of cancer. Support Care Cancer 3:45–60

    Article  PubMed  CAS  Google Scholar 

  10. Uitterhoeve RJ, Vernooy M, Litjens M, Potting K, Bensing J, De Mulder P, van Achterberg T (2004) Psychosocial interventions for patients with advanced cancer—a systematic review of the literature. Br J Cancer 91:1050–1062

    PubMed  CAS  Google Scholar 

  11. Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RK (2007) The treatment of depression in cancer patients: a systematic review. Support Care Cancer 15:123–136

    Article  PubMed  Google Scholar 

  12. Rayner L, Price A, Evans A, Valsraj K, Hotopf M, Higginson IJ (2011) Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliat Med 25:36–51

    Article  PubMed  Google Scholar 

  13. Stiefel R, Die Trill M, Berney A, Olarte JM, Razavi A (2001) Depression in palliative care: a pragmatic report from the Expert Working Group of the European Association for Palliative Care. Support Care Cancer 9:477–488

    Article  PubMed  CAS  Google Scholar 

  14. Jacobsen PB, Shibata D, Siegel EM, Lee JH, Fulp WJ, Alemany C, Abesada-Terk G, Jr, Brown R, Cartwright T, Faig D, Kim G, Levine R, Markham MJ, Schreiber F, Sharp P, Malafa M (2011) Evaluating the quality of psychosocial care in outpatient medical oncology settings using performance indicators. Psychooncology 20(11):1221–1227

    Google Scholar 

  15. Lloyd-Williams M, Dennis M, Taylor F (2004) A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliat Med 18:558–563

    Article  PubMed  Google Scholar 

  16. Laird BJ, Boyd AC, Colvin LA, Fallon MT (2009) Are cancer pain and depression interdependent? A systematic review. Psychooncology 18:459–464

    Article  PubMed  Google Scholar 

  17. Lo C, Zimmermann C, Rydall A, Walsh A, Jones JM, Moore MJ, Shepherd FA, Gagliese L, Rodin G (2010) Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. J Clin Oncol 28:3084–3089

    Article  PubMed  Google Scholar 

  18. Salvo N, Zeng L, Zhang L, Leung M, Khan L, Presutti R, Nguyen J, Holden L, Culleton S, Chow E (2012) Frequency of reporting and predictive factors for anxiety and depression in patients with advanced cancer. Clin Oncol (R Coll Radiol) 24(2):139–148

    Google Scholar 

  19. DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101–2107

    Article  PubMed  CAS  Google Scholar 

  20. Pelletier G, Verhoef MJ, Khatri N, Hagen N (2002) Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol 57:41–49

    Article  PubMed  Google Scholar 

  21. Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL (2009) Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int 75:1223–1229

    Article  PubMed  Google Scholar 

  22. Holland JC, Alici Y (2010) Management of distress in cancer patients. J Support Oncol 8:4–12

    PubMed  Google Scholar 

  23. Satin JR, Linden W, Phillips MJ (2009) Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 115:5349–5361

    Article  PubMed  Google Scholar 

  24. Lloyd-Williams M, Shiels C, Taylor F, Dennis M (2009) Depression—an independent predictor of early death in patients with advanced cancer. J Affect Disord 113:127–132

    Article  PubMed  Google Scholar 

  25. Mitchell AJ, Kaar S, Coggan C, Herdman J (2008) Acceptability of common screening methods used to detect distress and related mood disorders—preferences of cancer specialists and non-specialists. Psychooncology 17:226–236

    Article  PubMed  Google Scholar 

  26. Rhondali W, Perceau E, Blay JY, Fournel-Federico C, Saltel P, Trillet-Lenoir V, Tredan O, Coulon JP, Bruera E, Filbet M (2012) Depression assessment by oncologists and palliative care physicians. Palliat Support Care 10(4), in press

  27. Lees N, Lloyd-Williams M (1999) Assessing depression in palliative care patients using the visual analogue scale: a pilot study. Eur J Cancer Care (Engl) 8:220–223

    Article  CAS  Google Scholar 

  28. Vignaroli E, Pace EA, Willey J, Palmer JL, Zhang T, Bruera E (2006) The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med 9:296–303

    Article  PubMed  Google Scholar 

  29. Wasteson E, Brenne E, Higginson IJ, Hotopf M, Lloyd-Williams M, Kaasa S, Loge JH (2009) Depression assessment and classification in palliative cancer patients: a systematic literature review. Palliat Med 23:739–753

    Article  PubMed  Google Scholar 

  30. Dugan W, McDonald MV, Passik SD, Rosenfeld BD, Theobald D, Edgerton S (1998) Use of the Zung Self-Rating Depression Scale in cancer patients: feasibility as a screening tool. Psychooncology 7:483–493

    Article  PubMed  CAS  Google Scholar 

  31. Lloyd-Williams M, Shiels C, Dowrick C (2007) The development of the Brief Edinburgh Depression Scale (BEDS) to screen for depression in patients with advanced cancer. J Affect Disord 99:259–264

    Article  PubMed  Google Scholar 

  32. Rhondali W, Perceau E, Saltel P, Girard R, Filbet M (2011) Translation and validation of Brief Edinburgh Depression Scale (BEDS) in French. Bull Cancer 98:199–208

    PubMed  Google Scholar 

  33. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655

    Article  PubMed  CAS  Google Scholar 

  34. Cummings G, Biondo PD, Campbell D, Stiles C, Fainsinger R, Muise M, Hagen N (2011) Can the global uptake of palliative care innovations be improved? Insights from a bibliometric analysis of the edmonton symptom assessment system. Palliat Med 25:71–82

    Article  PubMed  Google Scholar 

  35. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9

    PubMed  CAS  Google Scholar 

  36. Chang VT, Hwang SS, Feuerman M (2000) Validation of the Edmonton Symptom Assessment Scale. Cancer 88:2164–2171

    Article  PubMed  CAS  Google Scholar 

  37. Richardson LA, Jones GW (2009) A review of the reliability and validity of the Edmonton Symptom Assessment System. Curr Oncol 16:55

    Article  PubMed  CAS  Google Scholar 

  38. Bruera E, MacMillan K, Hanson J, MacDonald RN (1989) The Edmonton staging system for cancer pain: preliminary report. Pain 37:203–209

    Article  PubMed  CAS  Google Scholar 

  39. Cheung WY, Barmala N, Zarinehbaf S, Rodin G, Le LW, Zimmermann C (2009) The association of physical and psychological symptom burden with time to death among palliative cancer outpatients. J Pain Symptom Manage 37:297–304

    Article  PubMed  Google Scholar 

  40. Moro C, Brunelli C, Miccinesi G, Fallai M, Morino P, Piazza M, Labianca R, Ripamonti C (2006) Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer 14:30–37

    Article  PubMed  Google Scholar 

  41. Carvajal A, Centeno C, Watson R, Bruera E (2011) A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patients. Eur J Cancer 47:1863–1872

    Article  PubMed  Google Scholar 

  42. Zeng L, Koo K, Zhang L, Jon F, Dennis K, Holden L, Nguyen J, Tsao M, Barnes E, Danjoux C, Sahgal A, Chow E (2011) Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic as screened by the Edmonton Symptom Assessment System. Support Care Cancer

  43. Kroenke K, Zhong X, Theobald D, Wu J, Tu W, Carpenter JS (2010) Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med 170:1686–1694

    Article  PubMed  Google Scholar 

  44. Laird BJ, Scott AC, Colvin LA, McKeon AL, Murray GD, Fearon KC, Fallon MT (2011) Pain, depression, and fatigue as a symptom cluster in advanced cancer. J Pain Symptom Manage 42:1–11

    Article  PubMed  Google Scholar 

  45. Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606–613

    Article  PubMed  CAS  Google Scholar 

  46. Thekkumpurath P, Walker J, Butcher I, Hodges L, Kleiboer A, O'Connor M, Wall L, Murray G, Kroenke K, Sharpe M. Screening for major depression in cancer outpatients: the diagnostic accuracy of the 9-item patient health questionnaire. Cancer 117(1):218–227

  47. Schroevers MJ, Sanderman R, van Sonderen E, Ranchor AV (2000) The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: depressed and positive affect in cancer patients and healthy reference subjects. Qual Life Res 9:1015–1029

    Article  PubMed  CAS  Google Scholar 

  48. Hann D, Winter K, Jacobsen P (1999) Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 46:437–443

    Article  PubMed  CAS  Google Scholar 

  49. Luckett T, Butow PN, King MT, Oguchi M, Heading G, Hackl NA, Rankin N, Price MA (2010) A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses. Support Care Cancer 18:1241–1262

    Article  PubMed  Google Scholar 

  50. Mitchell AJ (2010) Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis. J Natl Compr Canc Netw 8:487–494

    PubMed  Google Scholar 

  51. Johnston M, Pollard B, Hennessey P (2000) Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 48:579–584

    Article  PubMed  CAS  Google Scholar 

  52. Berard RM, Boermeester F, Viljoen G (1998) Depressive disorders in an out-patient oncology setting: prevalence, assessment, and management. Psychooncology 7:112–120

    Article  PubMed  CAS  Google Scholar 

  53. Yennurajalingam S, Urbauer DL, Casper KL, Reyes-Gibby CC, Chacko R, Poulter V, Bruera E (2010) Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manage. doi:10.1016/j.jpainsymman.2010.03.017

  54. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742

    Article  PubMed  CAS  Google Scholar 

  55. Hotopf M (2008) Review: screening or case-finding questionnaires used alone are not effective in the management of depression. ACP J Club 149:9

    PubMed  Google Scholar 

Download references

Acknowledgment

This research is supported by a grant from the Apicil Foundation.

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wadih Rhondali.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rhondali, W., Perceau, E., Berthiller, J. et al. Frequency of depression among oncology outpatients and association with other symptoms. Support Care Cancer 20, 2795–2802 (2012). https://doi.org/10.1007/s00520-012-1401-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-012-1401-3

Keywords

Navigation